Technology

View All

technology-and-autism-spectrum-disorder
Does the use of Assistive Technologies in Autism Spectrum Disorder Payoff?

Autism Spectrum Disorder (ASD) is a complex neurological and developmental condition that impacts a person’s social, communication, and behavioral aspects of life. It results in persistent restricted, repetitive patterns of behavior or interests.  It is a lifelong condition and mainly appears during the early ...

Find More

healthcare innovations
Top healthcare innovations changing the healthcare dynamics

William Blake, an English poet, painter, and printmaker, way back in 1803, said: "What is now proved was once only imagined.". The quote stays fit in today's highly innovative and technologically sophisticated society. Innovation has brought many life-saving products and services that have significantly improved th...

Find More

Women Healthcare
Where Women Healthcare Stands

Technology has made an impact on every field. And Healthcare is no exception. Advances in medical technology have proven to be a game-changer in the health sector. But is the case same when Women healthcare comes to mind? It will not be less than a shock to learn that Women were not included in medical research and...

Find More

Pulling the apoptotic trigger for necrosis

Apoptosis and necrosis are considered to be distinct modes of cell death; however, apoptosis can progress to secondary necrosis if apoptotic cells are not efficiently removed by phagocytic cells. Secondary necrosis was thought to be unregulated and to occur through passive cell swelling. However, research shows that...

Find More

Biosimilar Market in India

Today's opportunity for Indian companies in biosimilars is not much different from that of the generics industry in 1984. According to Ministry of Commerce and Industry, India’s pharmaceutical export segment has more than doubled from $ 7.8 billion in 2008 to $ 16.5 billion in 2014. With biologic treatments int...

Find More

Boston Biomedical starts phase III; Martindale receives approval; Merck snagged yes; Nanotechnology to improve HIV

Boston Biomedical starts phase III study of Napabucasin Boston Biomedical, an industry leader in the development of novel compounds designed to target cancer stemness pathways, announced dosing of the first patient in CanStem303C, a new global phase III study investigating napabucasin in combination with standard of...

Find More

Liquid Biopsy: Revolutionary Technique for Cancer Diagnosis

Clinicians have been conducting biopsies for a long time, for diagnosing and managing cancer, as genetic profile of tumor is analyzed through biopsy. Tissue biopsy is a traditional biopsy technique which is a time consuming and lengthy procedure, and cannot be performed routinely. Liquid Biopsy is a next generation ...

Find More

Delveinsight
DelveInsight’s Gene Therapy Reports: Launched

Immense Growth Potential in the Gene Therapy Market! DelveInsight has launched its Gene Therapy Report: “Gene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape”. These Reports are the outcome of very best analytical abilities and diligent market research amalgamated with opin...

Find More